Incaptek is a Swiss startup developing high-performance materials and innovative drug delivery systems. The company focuses on advanced materials technology for applications in electronics, automotive, aerospace, and medical technology.

Incaptek

INCAPTEK | 220 followers on LinkedIn. Swiss start-up developing advanced drug delivery systems for biotech/medtech and high-performance materials. | INCAPTEK Sàrl is a start-up from Switzerland developing advanced drug delivery systems and technologies to produce high-performance materials. 

We design smart micro(nano)encapsulation solutions and highly innovative materials for controlled and targeted drug delivery for biotech and medtech industries. We deliver drugs at the right place, in the right dosage, and at the right time, bringing treatment outcomes to the next level.

Co-founder and CEO at INCAPTEK Sàrl

Olga Fontanellaz

Yuri Moshkin

Bruno Hell

INCAPTEK

I am proud to share wonderful news! INCAPTEK has won the AdMaCom2024 award! It was inspiring to participate last Friday, 26 April 2024, in the #DemoDay , where 10 #DeepTech startups selected by INAM - Innovation Network for Advanced Materials presented their technologies. Many thanks to the AdMaCom team, particularly to Oliver Hasse, Christopher Daubney, and Nahida Chowdhury, for selecting INCAPTEK to participate and for organising the AdMaCom programme (it was fantastic!). Many thanks to all the amazing mentors, the jury, and everybody involved. We look forward to continuing to work with the INAM and its partners in the future. #AdMaComDemoDay #AdvancedMaterials #Innovation #openinnovation #Startups Florian Saner Tiphaine CHARRETIER Hayata Okubo Yuri Moshkin Tatiana Schneider-Neureither Carlos Correa

Metric
Company Name	Incaptek
Symbol
MSH ID	COM:INCAPTEK
Market	PRIVATE
Sector	Technology
Industry	Advanced Materials and Biotech
Country	CH
Stage
Employee Count
Website	incaptek.com
LinkedIn	incaptek
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

INCA

COM:INCAPTEK

Incaptek

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue